Berta Caballol

702 total citations
18 papers, 234 citations indexed

About

Berta Caballol is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Berta Caballol has authored 18 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Genetics and 7 papers in Surgery. Recurrent topics in Berta Caballol's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Berta Caballol is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Berta Caballol collaborates with scholars based in Spain, Switzerland and Italy. Berta Caballol's co-authors include Marco Sanduzzi‐Zamparelli, María Reig, Nicola Colucci, Jordi Bruix, Ferràn Torres, Víctor Sapena, Christian Toso, Lorenzo A. Orci, Sabela Lens and Josep Costa and has published in prestigious journals such as Journal of Hepatology, British journal of surgery and American Journal of Roentgenology.

In The Last Decade

Berta Caballol

16 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Berta Caballol Spain	6	176	140	34	26	25	18	234
Gangde Zhao China	12	267 1.5×	211 1.5×	40 1.2×	11 0.4×	34 1.4×	28	363
Hiroshi Isoda Japan	9	218 1.2×	181 1.3×	20 0.6×	12 0.5×	38 1.5×	23	301
Marcela Galoppo Argentina	8	133 0.8×	93 0.7×	28 0.8×	29 1.1×	20 0.8×	9	188
M. Marcolongo Italy	6	311 1.8×	286 2.0×	23 0.7×	16 0.6×	43 1.7×	8	353
Hesham M. Elgouhari United States	6	249 1.4×	175 1.3×	62 1.8×	13 0.5×	36 1.4×	13	303
Serag Esmat Egypt	9	120 0.7×	63 0.5×	86 2.5×	37 1.4×	19 0.8×	17	248
Cristina Galoppo Argentina	10	242 1.4×	234 1.7×	61 1.8×	61 2.3×	38 1.5×	16	354
G. Raimondo Italy	10	216 1.2×	220 1.6×	27 0.8×	11 0.4×	24 1.0×	23	296
C Gueli Italy	7	235 1.3×	242 1.7×	67 2.0×	18 0.7×	15 0.6×	7	318
Feyza Gündüz Türkiye	11	138 0.8×	113 0.8×	26 0.8×	37 1.4×	56 2.2×	27	284

Countries citing papers authored by Berta Caballol

Since Specialization

Citations

This map shows the geographic impact of Berta Caballol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berta Caballol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berta Caballol more than expected).

Fields of papers citing papers by Berta Caballol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berta Caballol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berta Caballol. The network helps show where Berta Caballol may publish in the future.

Co-authorship network of co-authors of Berta Caballol

This figure shows the co-authorship network connecting the top 25 collaborators of Berta Caballol. A scholar is included among the top collaborators of Berta Caballol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berta Caballol. Berta Caballol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Caballol, Berta, Íngrid Ordás, Maria Carme Masamunt, et al.. (2025). Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical Outcomes. United European Gastroenterology Journal. 13(7). 1217–1225. 1 indexed citations

Gudiño, Victòria, Berta Caballol, A M Corraliza, et al.. (2025). OP24 TL1A-activated T cells as upstream regulators of perianal fistulizing disease-associated changes in the rectum of Crohn's Disease patients. Journal of Crohn s and Colitis. 19(Supplement_1). i47–i49.

Caballol, Berta, Cristina Saavedra, A Fernández-Clotet, et al.. (2024). P276 Predictive value of changes in 3D volumetry in perianal fistulas in patients with Crohn’s disease under biologic therapy. A pilot study. Journal of Crohn s and Colitis. 18(Supplement_1). i636–i636. 2 indexed citations

Ferrer, Joana, Berta Caballol, Marco Sanduzzi‐Zamparelli, et al.. (2024). Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection. Journal of Hepatology. 81(6). 995–1004. 23 indexed citations

Iborra, Marisa, Berta Caballol, António Garrido, et al.. (2024). P516 Subcutaneous infliximab cut-off points in a large cohort of Spanish patients with inflammatory bowel disease and factors associated with long-term outcomes. Journal of Crohn s and Colitis. 18(Supplement_1). i1013–i1014. 2 indexed citations

Fernández-Clotet, A, Íngrid Ordás, Maria Carme Masamunt, et al.. (2024). Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease. Alimentary Pharmacology & Therapeutics. 59(11). 1435–1445. 4 indexed citations

Iborra, Marisa, Berta Caballol, José María Huguet, et al.. (2024). Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry. Journal of Crohn s and Colitis. 19(1). 2 indexed citations

Ordás, Íngrid, A Fernández-Clotet, Berta Caballol, et al.. (2023). De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice. Gastroenterología y Hepatología. 47(7). 673–682.

Rimola, Jordi, A Fernández-Clotet, Berta Caballol, et al.. (2023). ADC Values for Detecting Bowel Inflammation and Biologic Therapy Response in Patients With Crohn Disease: A Post Hoc Prospective Trial Analysis. American Journal of Roentgenology. 222(1). e2329639–e2329639. 5 indexed citations

10.

Fernández-Clotet, A, Julián Panés, Elena Ricart, et al.. (2022). Predictors of bowel damage in the long-term progression of Crohn’s disease. World Journal of Clinical Cases. 10(33). 12208–12220. 3 indexed citations

11.

Caballol, Berta, Juan Berenguer, Ibán Aldecoa, et al.. (2022). Clinically reversible ustekinumab-induced encephalopathy: case report and review of the literature. Therapeutic Advances in Neurological Disorders. 15. 4213360770–4213360770. 3 indexed citations

12.

Fernández‐Esparrach, Glòria, Cristina Rodríguez de Miguel, Maria Carme Masamunt, et al.. (2022). Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?. Diagnostics. 12(9). 2226–2226. 7 indexed citations

13.

Giordano, Antonio, Montserrat Rovira, Pedro Marı́n, et al.. (2022). P575 Safety and efficacy of autologous haematopoietic stem cell transplantation for refractory Crohn’s disease after cyclophosphamide-free mobilisation: Preliminary Results. Journal of Crohn s and Colitis. 16(Supplement_1). i516–i516. 1 indexed citations

14.

Orci, Lorenzo A., Marco Sanduzzi‐Zamparelli, Berta Caballol, et al.. (2021). Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression. Clinical Gastroenterology and Hepatology. 20(2). 283–292.e10. 135 indexed citations

15.

Orci, Lorenzo A., Berta Caballol, Marco Sanduzzi‐Zamparelli, et al.. (2021). Incidence of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: A meta-analysis and meta-regression. British journal of surgery. 108(Supplement_4). 2 indexed citations

16.

Caballol, Berta, Victòria Gudiño, Julián Panés, & Azucena Salas. (2021). Ulcerative colitis: shedding light on emerging agents and strategies in preclinical and early clinical development. Expert Opinion on Investigational Drugs. 30(9). 931–946. 7 indexed citations

17.

Caballol, Berta, Enric Reverter, Joan Cid, et al.. (2019). Fulminant hepatitis A complicated by Takotsubo syndrome successfully treated with standard volume plasma exchange. JHEP Reports. 1(6). 445–448. 2 indexed citations

18.

Rodríguez‐Tajes, Sergio, Berta Caballol, Sabela Lens, et al.. (2017). Hepatitis A outbreak in Barcelona among men who have sex with men (MSM), January‐June 2017: A hospital perspective. Liver International. 38(4). 588–593. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact